Table 2.
Evaluation method | Effect measures | |||
Study | Proces | Outcome | ||
Phillips [7] | Pre- and post intervention mean group differences on patients in intervention vs. control groups. | †Mean Hba1c. Mean Ldl Cholesterol. Blood pressure. |
||
Sequist [14] | Both summary and individual composite endpoints | †Cholesterol measured, Hba1c measured. Eye exam. ACE inh if hypertension. |
†Odds of receiving recommended diabetes care * | |
Summary endpoint: diabetes reminders resulting in action/diabetes reminders in total Individual endpoints: No. of appropriate diabetes health services received by pt/total no. of diabetes health services pt |
||||
Frijling [8] | Mean compliance rate for each performance indicator at baseline and the mean change from baseline. | †Foot exam. †Eye exam. BMI. Medication. Measured blood press. Anti diabetic treatment. Scheduled next appointment |
||
Lobach [9] | Mean compliance rate for each performance indicator at baseline and the mean change from baseline. Composite outcome of all performance indicators at baseline and the mean change from baseline. | †Physical exam †Urine protein measured. †Cholesterol measured. Eye exam. Influenza vac. Pneumococ vac. Foot exam. Hba1c measured. |
†Median level of compliance * †Median adherence rate of the clinicians * |
|
Nilasena [10] | Mean compliance rate for each performance indicator at baseline and the mean change from baseline. | Foot exam., physical exam. Hba1c measured. Urine protein measured. Cholesterol measured. Eye exam. Influenza vac. Pneumococ vac. |
||
Hetlevik [15] | Mean group differences in fractions of patients without registrations (process evaluation). | Mean group differences in variables (patient outcome evaluation) | Registered smoking habits. BMI. Blood pressure measured. Hba1c measured. Cholesterol measured. |
†Blood pressure. Number of smokers. BMI. Mean Hba1c. Mean cholesterol. |
Kenealy [11] | Was/not tested for blood glucose if eligible. | †Blood glucose measured | ||
Kiefe [16] | Proportional changes in the receiving of guideline specific diabetic services. | †Influenza vac. †Foot exam. †Hba1c measured, cholesterol measured. Triglycerides measured |
||
de Fine Olivarius [12] | Pre- and post intervention mean group differences on patients in intervention vs. control groups. | Measurement of blood glucose- Measurement of Hba1c. Measurement of blood pressure. Measurement of cholesterol. Measurement of triglycerides |
†Level of plasma glucose. †Level of Hba1c. †Level of blood pressure. †Cholesterol Mortality. Diabetic retinopathy. AMI. Stroke. Angina pectoris. Claudicatio, Amputation. |
|
Glasgow [13] | Effect of system evaluated on 2 primary outcomes: number of recommended laboratory screenings and recommended patient-centred care activities completed. Secondary outcomes were evaluated using the Problem Areas in Diabetes scale and the Patient Health Questionnaire. | †Foot exams. †Nutrition counselling Blood pressure measured. Eye exam. Foot exam. Micro albumin. |
†No of recommended lab assays * †Patient-centred aspects of diabetes care received * |
† = Significant positive changes.
* Composite outcome